DiaCarta Monkeypox Test Kit Issued Emergency Use Authorization by FDA
Earlier this month, the US Food and Drug Administration (FDA) issued an emergency use authorization for DiaCarta’s QuantiVirusTM MPXV test kit. The kit is a PCR test for monkeypox virus (MPXV) that tests for two separate regions of the MPXV genome to account for the chance of future mutations that would otherwise render the test void.
AJMC “What We’re Reading” – Uninsured Children, HIV and Monkeypox, and Health Outcomes by US State
In the latest edition of “What We’re Reading,” the AJMC staff cover several breaking stories. A recent study found that people living in conservative US states have lower life expectancies than more liberal ones. The researchers’ anaysis shows that over 170,000 lives could be saved if certain liberal policies were enacted nationwide. In other news, new data shows a striking comorbidity between monkeypox and HIV.
Real-World Data Shines in Monkeypox Vaccine Efforts
Much like the COVID-19 pandemic, the global monkeypox outbreak and subsequent vaccine development and distribution efforts have highlighted the utility of real-world data (RWD). An example has been the push towards intradermal administration of Bavarian Nordic’s Jynneos monkeypox vaccine, a move done to stretch reserves in the midst of a then-pressing shortage. RWD has helped researchers investigate this application despite not having major randomized controlled trials (RCTs).
Bavarian Nordic Nets $470 Million in Updated Deal Monkeypox Vaccine Deal with Canada
The Canadian government has extended a deal with the vaccine manufacturer Bavarian Nordic for Jynneos (Imvamune in Canada), its monkeypox vaccine. The updated deal adds another $234 million in vaccine doses in the short-term and $180 million in doses doled out in batches through 2032.
Bavarian Nordic Boosts Production of Monkeypox Vaccine
Paul Chaplin, CEO Bavarian Nordic announced during a call with investors that the company has leaned heavily into production of bulk Jynneos, its monkeypox vaccine. The news comes shortly after the company made a deal with Grand River Aseptic Manufacturing to fill vials from bulk vaccine in the US. Bavarian Nordic is now dedicating all of its production capacity to Jynneos, sidelining its other vaccines
US Government Announces Plans for Domestic Monkeypox Vaccine Production
In an announcement last week, the US Department of Health and Human Services (DHS) revealed a new deal between Bavarian Nordic and Grand River Aseptic Manufacturing (GRAM). The agreement will allow GRAM to manufacture Bavarian Nordic’s Jynneos monkeypox vaccine stateside. GRAM will produce 2.5 million vials from bulk vaccine, hopefully ramping up access for at-risk populations.
US Government Eyes Transdermal Vaccinations for Monkeypox
As cases of monkeypox rise in the US, unnamed sources are indicating the government will push for transdermal injection for Jyneos, the monkeypox vaccine produced by Bavarian Nordic. The scale of the outbreak, which resulted in a declaration of a national health emergency just last week, combined with the small supply of the vaccine has officials looking into resource-saving measures. The procedure requires just one-fifth the dose of the standard subcutaneous injection route, but requires specialized training to perform.
Bavarian Nordic Makes Deal to Provide 1.5M Monkeypox Vaccine Doses to Unnamed European Country
The Danish drugmaker Bavarian Nordic has signed a deal with another unnamed European nation, this time promising 1.5 million doses of its monkeypox vaccine. This is the second deal with undisclosed European countries and comes hot off the heels of a deal with the US govt for 2.5 million.
Novavax COVID-19 Vaccine Gets Emergency Use Authorization from FDA
The US Department of Health and Human Services (HHS) has announced that 780,000 doses of Bavarian Nordic’s should be headed to the US by the end of the month. The vaccines, at Bavarian Nordic’s Denmark facilities, are currently undergoing an FDA inspection and authorization. The announcement comes as the disease pops up across the country.
780,000 Doses of Bavarian Nordic Monkeypox Vaccine to be Shipped to US by End of July
The US Department of Health and Human Services (HHS) has announced that 780,000 doses of Bavarian Nordic’s should be headed to the US by the end of the month. The vaccines, at Bavarian Nordic’s Denmark facilities, are currently undergoing an FDA inspection and authorization. The announcement comes as the disease pops up across the country.
Labcorp Ramps Up Monkeypox Testing Capabilities
As monkeypox continues to spread across the world, Labcorp has announced that it is increasing its testing capabilities at its [...]
Politico Pulse: Addressing Monkeypox Antiviral Shortages
As monkeypox cases continue to spring up across the world, nations are seeking to stock up on the antiviral tecovirimat. [...]
Learning from the AIDS Crisis to Combat Monkeypox
As the monkeypox outbreak spreads across the world, public health experts and decisionmakers look back to the peak of the [...]
Bavarian Nordic in Talks with Governments to Produce Monkeypox Vaccines
As more cases of monkeypox spring up across the world, the German government has ordered 40,000 doses of monkeypox vaccines [...]
